127 related articles for article (PubMed ID: 27473013)
1. Lack of TAK1 in dendritic cells inhibits the contact hypersensitivity response induced by trichloroethylene in local lymph node assay.
Yao P; Hongqian C; Qinghe M; Lanqin S; Jianjun J; Xiaohua Y; Xuetao W; Weidong H
Toxicol Appl Pharmacol; 2016 Sep; 307():72-80. PubMed ID: 27473013
[TBL] [Abstract][Full Text] [Related]
2. The critical role for TAK1 in trichloroethylene-induced contact hypersensitivity in vivo and in CD4
Pan Y; Hou X; Meng Q; Yang X; Shang L; Wei X; Hao W
Toxicol Appl Pharmacol; 2019 Oct; 380():114705. PubMed ID: 31400415
[TBL] [Abstract][Full Text] [Related]
3. An essential role for TAK1 in the contact hypersensitivity response.
Zhao YG; Wang Y; Hao W; Wan YY
Cell Mol Immunol; 2011 Jul; 8(4):315-24. PubMed ID: 21552285
[TBL] [Abstract][Full Text] [Related]
4. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.
Cao H; Lu J; Du J; Xia F; Wei S; Liu X; Liu T; Liu Y; Xiang M
Sci Rep; 2015 Oct; 5():14593. PubMed ID: 26459028
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function.
Wang Y; Huang G; Vogel P; Neale G; Reizis B; Chi H
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):E343-52. PubMed ID: 22308391
[TBL] [Abstract][Full Text] [Related]
7. Oxazolone-induced contact hypersensitivity reduces lymphatic drainage but enhances the induction of adaptive immunity.
Aebischer D; Willrodt AH; Halin C
PLoS One; 2014; 9(6):e99297. PubMed ID: 24911791
[TBL] [Abstract][Full Text] [Related]
8. Role of transforming growth factor-activated kinase-1 on tumor necrosis factor-α actions in human adipose tissue-derived stromal cells.
Lee SY; Lee JH; Shin KK; Kim DS; Kim YS; Bae YC; Jung JS
Stem Cells Dev; 2015 Apr; 24(7):836-45. PubMed ID: 25350220
[TBL] [Abstract][Full Text] [Related]
9. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice.
Tang M; Wei X; Guo Y; Breslin P; Zhang S; Zhang S; Wei W; Xia Z; Diaz M; Akira S; Zhang J
J Exp Med; 2008 Jul; 205(7):1611-9. PubMed ID: 18573910
[TBL] [Abstract][Full Text] [Related]
10. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
[TBL] [Abstract][Full Text] [Related]
11. IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity.
Girard-Madoux MJ; Kel JM; Reizis B; Clausen BE
J Allergy Clin Immunol; 2012 Jan; 129(1):143-50.e1-10. PubMed ID: 21975175
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expression in trichloroethylene-induced hypersensitivity dermatitis: an in vivo and in vitro study.
Jia Q; Zang D; Yi J; Dong H; Niu Y; Zhai Q; Teng Y; Bin P; Zhou W; Huang X; Li H; Zheng Y; Dai Y
Toxicol Lett; 2012 Nov; 215(1):31-9. PubMed ID: 23041168
[TBL] [Abstract][Full Text] [Related]
14. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
Gerberick GF; Cruse LW; Ryan CA
Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
[TBL] [Abstract][Full Text] [Related]
15. Irisflorentin modifies properties of mouse bone marrow-derived dendritic cells and reduces the allergic contact hypersensitivity responses.
Fu RH; Tsai CW; Tsai RT; Liu SP; Chan TM; Ho YC; Lin HL; Chen YM; Hung HS; Chiu SC; Tsai CH; Wang YC; Shyu WC; Lin SZ
Cell Transplant; 2015; 24(3):573-88. PubMed ID: 25654487
[TBL] [Abstract][Full Text] [Related]
16. Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation.
Chen IT; Hsu PH; Hsu WC; Chen NJ; Tseng PH
Sci Rep; 2015 Jul; 5():12300. PubMed ID: 26189595
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of IL-12 synthesis by human dendritic cells treated with the chemical sensitizer NiSO4.
Antonios D; Rousseau P; Larangé A; Kerdine-Römer S; Pallardy M
J Immunol; 2010 Jul; 185(1):89-98. PubMed ID: 20525893
[TBL] [Abstract][Full Text] [Related]
18. TAK1: Another mesh in the NF-κB - JNK controlled network causing hepatocellular carcinoma.
Greten FR
J Hepatol; 2011 Sep; 55(3):721-723. PubMed ID: 21601601
[TBL] [Abstract][Full Text] [Related]
19. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways.
Zhu W; Yan H; Li S; Nie W; Fan F; Zhu J
Int Immunopharmacol; 2016 Dec; 41():24-34. PubMed ID: 27792919
[TBL] [Abstract][Full Text] [Related]
20. TAK1-JNK axis mediates survival signal through Mcl1 stabilization in activated T cells.
Hirata Y; Sugie A; Matsuda A; Matsuda S; Koyasu S
J Immunol; 2013 May; 190(9):4621-6. PubMed ID: 23547112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]